Pliant Therapeutics (PLRX) Asset Utilization Ratio (2020 - 2025)

Pliant Therapeutics (PLRX) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.0 as the latest value for Q1 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 549.03% to 0.0 in Q1 2025 year-over-year; TTM through Mar 2025 was 0.0, a 549.03% decrease, with the full-year FY2023 number at 0.0, down 89.19% from a year prior.
  • Asset Utilization Ratio was 0.0 for Q1 2025 at Pliant Therapeutics, down from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.05 in Q1 2021 to a low of 0.0 in Q1 2025.
  • A 5-year average of 0.02 and a median of 0.02 in 2022 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: decreased 19.87% in 2022, then crashed 549.03% in 2025.
  • Pliant Therapeutics' Asset Utilization Ratio stood at 0.03 in 2021, then decreased by 19.87% to 0.03 in 2022, then plummeted by 88.72% to 0.0 in 2023, then tumbled by 84.02% to 0.0 in 2024, then tumbled by 549.03% to 0.0 in 2025.
  • Per Business Quant, the three most recent readings for PLRX's Asset Utilization Ratio are 0.0 (Q1 2025), 0.0 (Q1 2024), and 0.0 (Q4 2023).